The panel discussion covered the barriers to understanding how cannabis can be used to alleviate chronic pain and potentially ease the opioid crisis.
“We shared our pain-patch with leading pain doctors in the region and they were all excited”; Preliminary studies on pain-patch shows excellent results” said Bobban Subhadra, M.S., Ph.D, Chief Operating Officer of Apotheca.
Combining cannabinoids with radiotherapy and smart biomaterials could enhance therapeutic efficacy during the treatment of pancreatic and lung cancers.
Current evidence suggests that medicinal cannabis could be a less dangerous alternative to current drugs on the market.
Molecular and advanced functional imaging are to be used to compare the brain effects of placebo, THC, and CBD related to attention, memory, processing of novelty and change as well as stress and pain.
Study marks one of the first attempts by U.S. scientists to assess how cannabis with varying concentrations of THC and CBD affect medicinal cannabis users’ feelings of well-being when smoked outside of a laboratory.
The funding will support research to investigate whether medicinal cannabinoid therapies can alleviate symptoms in children with severe autism—and if so, how.
In a small pilot study, patients using high CBD strains exhibited lower levels of circulating cytokines a marker of inflammation often associated with pain - than those using higher THC products.